Pruden. Sugar (PRUDMOULI)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a 35% discount to book value: P/B of 0.65 vs book value of ₹28 per share
• Low trailing P/E of 9.82 with strong recent sales and profit growth
• Piotroski F-Score of 7/9 indicates improving financial fundamentals
• Promoter holding of 56.55% aligns management with minority shareholders

Concerns

• ROE of 5.01% and ROCE of 7.66% signal weak capital efficiency and no clear moat
• No dividend yield, so returns depend entirely on price appreciation
• Latest quarter net margin is only about 3% (₹2 Cr profit on ₹67 Cr sales), leaving little room for error
• Debt/Equity is not available; leverage risk is unknown in a cyclical sugar business

AI Analysis

At ₹18.13, this stock trades at 0.65 times book value and under ten times earnings. Book value is ₹28 per share, so the market is offering a margin of safety on the balance sheet. But I always remind myself: a bargain is only worthwhile if the business can produce value. Here ROE is just 5.01% and ROCE is 7.66%; those are far below what I expect from a company with durable competitive advantages. Sugar is a commodity, and this business appears to be a price-taker with no obvious moat. The 106% sales growth and 59% profit growth are striking, but in a cyclical commodity business, a single upswing can make ordinary results look extraordinary. The latest quarter's ₹67 Cr in sales yielded only ₹2 Cr in net profit, a razor-thin 3% margin, so the earnings power is fragile. On the positive side, promoter holding is healthy at 56.55%, and the Piotroski score of 7/9 suggests the recent improvements may have some substance. With a PEG of 0.12, the market appears to be pricing in continued fast growth; I would hesitate to pay for that in a commodity business. The absence of a dividend means I must rely entirely on asset realization or a sustained sugar up-cycle to make money. Debt/Equity is not disclosed, which bothers me in this industry. I see this as a cyclical asset-backed opportunity, not a wonderful franchise. It may deserve a place on a watchlist, but I need better returns on capital and clarity on leverage before committing capital.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer